Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01192 |
| Species: | Homo sapiens |
| Position : | chr12:9916938-9918379 |
| Year: | 2020 |
| Title: | Functional Characterization of a Dual Enhancer/Promoter Regulatory Element Leading Human CD69 Expression |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 33193627 |
| MONDO: | |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Jurkat T cells |
| CVCL ID: | CVCL_0065 |
| Cell Type: | T lymphoblast |
| Cell Ontology ID: | CL:0002419 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay, TF binding assay |
| High Throughput Method: | RNA-seq, ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, ChIP-qPCR, RT-qPCR |
| Target gene : | CD69 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01193 | chr12:9916938-9918379 | Lymph node | B cell | -- |